PDF-ikonPrintikon

Paulo Rabna awarded PhD


25 February 2009  

Rabna 2008
Paulo Rabna successfully defended his PhD thesis

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Marker of Tuberculosis Treatment Efficacy and Potential Prognostic marker for Survival in individuals with a TB negative diagnosis. A prospective, Longitudinal Cohort Study in Suspected Pulmonary Tuberculosis patients in Guinea-Bissau

Statens Serum Institut, 24 February 2009

See also: Rabna PhD Dissertation

Bandim Health Project, Statens Serum Institut. Faculty of Health Sciences, University of Copenhagen







Last revised 25 February 2009

Related Content: Press

See also: BHP in the Press

Bandim Health Project

BHP logo

Contact

Bandim Health Project

Statens Serum Institut 
Building 206, ground floor
5 Artillerivej 
DK-2300 Copenhagen S
Denmark

Phone: 0045 3268 3162
Email:  
Web: http://bandim.org

Projecto de Saúde Bandim
Apartado 861
1004 Bissau codex
Guinea-Bissau

Phone: 00245 2014 89
Fax: 00245 201672